经验性131I放射性碘治疗甲状腺球蛋白升高而碘扫描阴性的分化型甲状腺癌患者的疗效:系统评价与荟萃分析
该系统评价与荟萃分析纳入截至2022年4月发表的14项研究、共690例因甲状腺球蛋白升高而碘扫描阴性(TENIS)综合征接受经验性大剂量放射性碘治疗的分化型甲状腺癌患者。微转移患者治疗后出现诊断性全身扫描未见的额外病灶(比例0.64,95%CI 0.51-0.77)且血清甲状腺球蛋白降低(比例0.69,95%CI 0.52-0.84),大转移患者未见此类表现;经验性放射性碘治疗组血清甲状腺球蛋白低于对照组(OR=0.27,95%CI 0.09-0.87),提示疾病进展风险较低。作者认为经验性大剂量放射性碘治疗对TENIS综合征患者有益,可推荐用于该人群,尤其是微转移患者。
要点
- 14项研究、690例TENIS综合征患者接受经验性大剂量放射性碘治疗。
- 微转移患者治疗后新发现病灶比例0.64(95%CI 0.51-0.77)、甲状腺球蛋白降低比例0.69(95%CI 0.52-0.84)。
- 经验性放射性碘治疗组血清甲状腺球蛋白低于对照组(OR=0.27,95%CI 0.09-0.87)。
核心结论
- 作者认为经验性大剂量放射性碘治疗对TENIS综合征患者产生有益效果,可推荐用于该人群,尤其是微转移患者。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、EMBASE和Cochrane Library截至2022年4月发表的相关研究,按PRISMA清单执行并在PROSPERO注册。
- 纳入14项研究、共690例因TENIS综合征接受经验性大剂量放射性碘治疗的患者。
- 采用比例和比值比的荟萃分析评估疗效,并按微转移或大转移进行亚组分析。
主要发现
- 微转移患者经验性放射性碘治疗后出现诊断性全身扫描未见的额外病灶(比例0.64,95%CI 0.51-0.77)。
- 微转移患者经验性放射性碘治疗后血清甲状腺球蛋白降低(比例0.69,95%CI 0.52-0.84)。
- 大转移患者中未观察到上述表现。
- 经验性放射性碘治疗组血清甲状腺球蛋白低于对照组(OR=0.27,95%CI 0.09-0.87),提示疾病进展风险较低。
关键数值与推荐
- 微转移患者新发现病灶比例0.64(95%CI 0.51-0.77)。
- 微转移患者血清甲状腺球蛋白降低比例0.69(95%CI 0.52-0.84)。
- 经验性放射性碘治疗组与对照组血清甲状腺球蛋白比较的OR=0.27(95%CI 0.09-0.87)。
临床怎么用
- 作者认为经验性大剂量放射性碘治疗可推荐用于TENIS综合征患者,尤其是微转移患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to perform a systematic review and meta-analysis on the efficacy of empirical high-dose radioiodine therapy in treating differentiated thyroid cancer patients with thyroglobulin (Tg)-elevated negative iodine scintigraphy (TENIS) syndrome. METHODS: We searched PubMed, EMBASE, and the Cochrane Library to identify relevant studies published until April 2022. This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist and registered in an international prospective register of systematic reviews (PROSPERO). Meta-analyses of proportions and odds ratios were performed to assess the beneficial effect of empirical high-dose radioiodine therapy in patients with TENIS syndrome. Subgroup analysis was also performed according to the presence of micrometastasis or macrometastasis. RESULTS: We identified 14 studies including 690 patients who received empirical high-dose radioiodine therapy for TENIS syndrome. Those who had micrometastasis exhibited additional lesions not previously observed on diagnostic whole-body scan (prop = 0.64, 95% confidence interval [CI], 0.51-0.77) and had reduced serum Tg levels (prop = 0.69; 95% CI, 0.52-0.84) after empirical radioiodine treatment. No such findings were observed among patients with macrometastasis. Moreover, we found that the empirical radioiodine treatment group had lower serum Tg levels than did controls (odds ratio = 0.27; 95% CI, 0.09-0.87), which suggests a lower risk of disease progression. CONCLUSIONS: Our findings indicate that empirical high-dose radioiodine therapy promoted beneficial effects and could be recommended for patients with TENIS syndrome, especially those with micrometastasis.
引用
- Kim K, Hong CM, Ha M, et al. Efficacy of Empirical 131 I Radioiodine Therapy in Well-Differentiated Thyroid Carcinoma Patients With Thyroglobulin-Elevated Negative Iodine Scintigraphy Syndrome : A Systematic Review and Meta-analysis. Clin Nucl Med. 2024. PMID: 38861375. doi:10.1097/RLU.0000000000005250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。